Cytotheryx Secures City Council Sponsorship for Major Funding Application

We are thrilled to share that the Rochester City Council has approved sponsoring Cytotheryx for applications to the Minnesota Department of Employment and Economic Development for the Minnesota Investment Fund and the Minnesota Job Creation Fund. We are hoping to secure a total of $870,000 in funding to support expansion in Rochester to further our mission.

Cytotheryx Secures City Council Sponsorship for Major Funding Application

Exciting Growth Ahead for Cytotheryx in Rochester

We are thrilled to share that the Rochester City Council has approved sponsoring Cytotheryx for applications to the Minnesota Department of Employment and Economic Development for the Minnesota Investment Fund and the Minnesota Job Creation Fund. We are hoping to secure a total of $870,000 in funding to support expansion in Rochester to further our mission.

Impact on the Community

This funding will play a crucial role in creating 22 new jobs within Rochester, home to the Mayo Clinic and other leading scientific institutions. John Wade, President of Rochester Area Economic Development, emphasized the strategic advantage of Cytotheryx’ growth in this vibrant scientific community.

Expanding Our Capabilities

With this funding, Cytotheryx plans to enhance our production capabilities expand our research and development laboratory and position the Company for the next phase of expansion. The new lab space will be a critical step in our growth in Rochester and in the greater biotech community.

Looking Forward

We are optimistic that the funding will be approved within the next 60 days. This support will enable us to pay competitive wages, attracting top talent to further our innovative work.

Stay tuned for more updates as we continue to expand and make strides in liver health technology.

For more information, visit the Rochester Area Economic Development website.

Featured Content

Covid-19 Statement

We are committed to our work and the wellness of our communities, and will remain so during this challenging and uncertain time of COVID-19.

Read More »